Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Guidant Johnson & Johnson vote ahead, but more ICD failures

This article was originally published in Clinica

Executive Summary

Guidant's shareholders will meet at an EGM on January 31 to vote on whether to accept the $21.5bn offer for the company from Johnson & Johnson. J&J's offer is $3.9bn less than its late-2004 bid of $25.4bn, but Guidant's product recalls in the summer forced J&J to review its offer in November. The date of the vote was set following the Securities and Exchange Commission's declaration on December 28 that the amended and restated merger agreement was "effective".

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT058291

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel